APA (7th ed.) Citation

Escalante Romero, L., Queiroz Costa Neto, I., Antunes, V., Matos Correia Rodrigues, M., Polo Mercado, J., & Monteiro Caran, E. (2024). 1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review. Annals of Oncology, 35, S694. https://doi.org/10.1016/j.annonc.2024.08.1089

Chicago Style (17th ed.) Citation

Escalante Romero, L., I. Queiroz Costa Neto, V.L.J Antunes, M. Matos Correia Rodrigues, J.R Polo Mercado, and E. Monteiro Caran. "1030P Survival Rates in High-risk Neuroblastoma Patients Undergoing Anti-GD2 Immunotherapy: A Single Arm Meta-analysis and Systemic Review." Annals of Oncology 35 (2024): S694. https://doi.org/10.1016/j.annonc.2024.08.1089.

MLA (9th ed.) Citation

Escalante Romero, L., et al. "1030P Survival Rates in High-risk Neuroblastoma Patients Undergoing Anti-GD2 Immunotherapy: A Single Arm Meta-analysis and Systemic Review." Annals of Oncology, vol. 35, 2024, p. S694, https://doi.org/10.1016/j.annonc.2024.08.1089.